Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment

被引:10
|
作者
Morrow, Eric M. [1 ,2 ,3 ,4 ]
Kane, Anna [1 ,2 ,3 ]
Goff, Donald C. [4 ]
Walsh, Christopher A. [1 ,2 ,3 ]
机构
[1] Harvard Univ, Childrens Hosp Boston, Sch Med, Div Genet, Boston, MA 02115 USA
[2] Howard Hughes Med Inst, Div Neurogenet, Chevy Chase, MD USA
[3] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA USA
[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat,Schizophrenia Res Program, Boston, MA 02114 USA
关键词
Schizophrenia; Mental retardation; Pfropfschizophrenie; P21-activated kinase PAK3; Cognitive development;
D O I
10.1016/j.schres.2008.08.021
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The P27-activated kinase PAK3 is critical for cognitive development and truncating mutations cause non-syndromic mental retardation (MR). Missense mutations are also associated with psychotic disorders, most commonly with schizophrenia involving premorbid MR, namely "pfropfschizophrenie". We set out to measure the frequency of sequence variants in PAK3 in schizophrenia without premorbid MR. We conducted complete gene reseqeuncing of all coding exons and exon-intron boundaries in patients with schizophrenia with cognitive impairment but without premorbid MR. Deleterious variants in schizophrenia alone were rare (<1/ 159 or 0.6%). Thereby, while PAK3 remains a strong biological candidate in psychosis, evidence from human genetics provides strongest support for a link to pfropfschizophrenie and not to schizophrenia without premorbid intellectual disability. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:265 / 267
页数:3
相关论文
共 50 条
  • [21] Multisite autophosphorylation of p21-activated protein kinase γ-PAK as a function of activation
    Gatti, A
    Huang, ZD
    Tuazon, PT
    Traugh, JA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) : 8022 - 8028
  • [22] Involvement of p21-activated kinase, γ-PAK, in endothelial cell retraction.
    Zeng, O
    Lagunoff, D
    Masaracchia, R
    Wysolmerski, RB
    FASEB JOURNAL, 1999, 13 (04): : A84 - A84
  • [23] Expression of P21-activated protein kinase γ-PAK in mammalian cells.
    Huang, ZD
    Traugh, JA
    FASEB JOURNAL, 1999, 13 (07): : A1578 - A1578
  • [24] Regulatory role of p21-activated kinase (PAK) on pinocytosis in fibroblasts.
    Dharmawardhane, S
    Sells, MA
    Chernoff, J
    Schuerman, A
    Teckerly, L
    Schmid, S
    Bokoch, G
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 463A - 463A
  • [25] Relationship of p21-Activated Kinase (PAK) and Filopodia to Persistence and Oncogenic Transformation
    Heckman, Carol A.
    Demuth, John G.
    Deters, Donald
    Malwade, Santosh R.
    Cayer, Marilyn L.
    Monfries, Clinton
    Mamais, Adamantios
    JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 220 (03) : 576 - 585
  • [26] Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2
    Goeckeler, ZM
    Masaracchia, RA
    Zeng, Q
    Chew, TL
    Gallagher, P
    Wysolmerski, RB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) : 18366 - 18374
  • [27] p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1)
    King, CC
    Gardiner, EMM
    Zenke, FT
    Bohl, BP
    Newton, AC
    Hemmings, BA
    Bokoch, GM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) : 41201 - 41209
  • [28] Analysis of activation of the P21-activated protein kinase γ-PAK by site-directed mutagenesis.
    Jakobi, R
    Huang, Z
    Walter, BN
    Tuazon, PT
    Traugh, JA
    FASEB JOURNAL, 1998, 12 (08): : A1369 - A1369
  • [29] Characterization of the substrate specificity of p21-activated protein kinase (PAK) I.
    Tuazon, PT
    Spanos, WC
    Chinwah, M
    Traugh, JA
    FASEB JOURNAL, 1997, 11 (03): : 1897 - 1897
  • [30] p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity
    Guo, Ping
    Liu, Yufeng
    Feng, Jingrong
    Tang, Shihang
    Wei, Fanyan
    Feng, Jian
    ARCHIVES OF TOXICOLOGY, 2022, 96 (12) : 3143 - 3162